One important manifestation of cytopathology for many viruses is the inhibition of host cell macromolecular synthesis. We have recently shown that the matrix (M) protein of the prototype rhabdovirus, vesicular stomatitis virus (VSV), is capable of inhibiting the host-directed transcription of target genes in vivo in the absence of any other viral component. The goal of this project is to define the role of the M protein in virus-induced cytopathology and determine its mechanism of action. The M proteins of viruses isolated from persistent VSV infections will be characterized to determine the minimal M protein sequence required for inhibition and whether or not mutations in the M gene contribute to the reduced cytopathic effects of these viruses. Mutational analysis of the M protein will also be used to determine whether or not nuclear localization is required for inhibition of host gene expression. The relative sensitivity of different host genes to inhibition of their transcription by M protein will be determined and the factors that govern susceptibility to M protein-induced inhibition will be mapped. The mechanism of the M protein-induced inhibition of gene expression will be investigated using an in vitro transcription system to determine the step(s) that are inhibited by M protein These studies should provide new information on the mechanisms by which viruses cause pathological effects in their host cells and on the mechanisms by which viruses establish persistent infections in which their cytopathic effects are reduced. In addition, these studies have the potential to yield novel anti-viral strategies based on enhancement of cellular resistance to virus-induced damage to the host and reduction of virus replication.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI032983-01A2
Application #
2067939
Study Section
Virology Study Section (VR)
Project Start
1994-05-01
Project End
1997-04-30
Budget Start
1994-05-01
Budget End
1995-04-30
Support Year
1
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Wake Forest University Health Sciences
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
041418799
City
Winston-Salem
State
NC
Country
United States
Zip Code
27106
Westcott, Marlena M; Liu, Jingfang; Rajani, Karishma et al. (2015) Interferon Beta and Interferon Alpha 2a Differentially Protect Head and Neck Cancer Cells from Vesicular Stomatitis Virus-Induced Oncolysis. J Virol 89:7944-54
Yu, Nanmeng; Puckett, Shelby; Antinozzi, Peter A et al. (2015) Changes in Susceptibility to Oncolytic Vesicular Stomatitis Virus during Progression of Prostate Cancer. J Virol 89:5250-63
Smedberg, Jason R; Westcott, Marlena M; Ahmed, Maryam et al. (2014) Signaling pathways in murine dendritic cells that regulate the response to vesicular stomatitis virus vectors that express flagellin. J Virol 88:777-85
Blackham, Aaron U; Northrup, Scott A; Willingham, Mark et al. (2014) Molecular determinants of susceptibility to oncolytic vesicular stomatitis virus in pancreatic adenocarcinoma. J Surg Res 187:412-26
Blackham, Aaron U; Northrup, Scott A; Willingham, Mark et al. (2013) Variation in susceptibility of human malignant melanomas to oncolytic vesicular stomatitis virus. Surgery 153:333-43
Westcott, Marlena M; Ahmed, Maryam; Smedberg, Jason R et al. (2013) Preservation of dendritic cell function during vesicular stomatitis virus infection reflects both intrinsic and acquired mechanisms of resistance to suppression of host gene expression by viral M protein. J Virol 87:11730-40
Stewart 4th, J H; Ahmed, M; Northrup, S A et al. (2011) Vesicular stomatitis virus as a treatment for colorectal cancer. Cancer Gene Ther 18:837-49
Gerlier, Denis; Lyles, Douglas S (2011) Interplay between innate immunity and negative-strand RNA viruses: towards a rational model. Microbiol Mol Biol Rev 75:468-90, second page of table of
Cary, Zachary D; Willingham, Mark C; Lyles, Douglas S (2011) Oncolytic vesicular stomatitis virus induces apoptosis in U87 glioblastoma cells by a type II death receptor mechanism and induces cell death and tumor clearance in vivo. J Virol 85:5708-17
Ahmed, M; Puckett, S; Lyles, D S (2010) Susceptibility of breast cancer cells to an oncolytic matrix (M) protein mutant of vesicular stomatitis virus. Cancer Gene Ther 17:883-92

Showing the most recent 10 out of 32 publications